Using pharmacokinetics for tailoring prophylaxis in people with hemophilia switching between clotting factor products: A scoping review-Reference-Cited by-同舟云学术

Using pharmacokinetics for tailoring prophylaxis in people with hemophilia switching between clotting factor products: A scoping review

Published:2019-05-20 Issue:3 Volume:3 Page:528-541
ISSN:2475-0379
Container-title:Research and Practice in Thrombosis and Haemostasis
language:en
Short-container-title:Res Pract Thromb Haemost

Author:

Yu Jacky K.¹,Iorio Alfonso²³,Edginton Andrea N.¹^ORCID,Ahuja Sanjay,Álvarez Román Ma Teresa,Arrieta Ma E.,Arola Mikko,Barillari Giovanni,Balasa Vinod,Belletrutti Mark,Berrueco Moreno Ruben,Beurrier Philippe,Bidlingmaier Cristoph,Blanchette Victor,Blatny Jan,Bonanad Santiago,Brose Kelsey,Brown Deborah,Byant Paulette C.,Canaro Mariana,Carvalho Manuela,Catarino Cristina,Chitlur Meera,Cockrell Erin,Chowdary Pratima,Cnossen Marjon,Collins Peter,Coppens Michial,Croteau Stacy,Cultrera Dorina,Cristofaro Raimundo,Raucourt Emmauelle,Desprez Dominique,Dunn Amy,El‐Ekiabi Magda,Faganel Kotnik Barbara,Fischer Kathleen,Frotscher Brigit,Garbiero Susana,Garrido Ruiz Raquel,Gill Joan,Gomez del Castillo Carmen,Gottstein Saskia,Lassandro Giuseppe,Giordano Paola,Hart Daniel,Hegemann Inga,Hermans Cedric,Hua Baolai,Hwang Nina,Jackson Shannon,James Paula,Katsarou Olga,Kavakli Kaan,Kempton Christine,Kentouche Karim,Khan Osman,Kobelt Rainer,Kruse‐Jarres Rebecca,Laane Edward,Larson Eric,Lassila Riitta,Lee Adrienne,Poon Man‐Chiu,Lissick Jennifer,Langstrom Satu,Mahlangu Johnny,Makris Michael,Marchesini Emmanuela,Mateo Jose,Marco Vera Pacual,Martorell Marta,Matsushita Tadashi,McCrae Simon,Mignot‐Castellano Eva,Montcrieff Caitlin,Maes Philip,Mondelars Veerle,Bekart Marlies,Mora Elena,Cristóbal Morales Juan,Mourey Guillaume,Bertrand Marie Ann,Napolitano Mariasanta,Siragusa Sergio,Negrier Claude,Neme Daniela,Niinimaki Ritta,Oldenburg Johannes,Albert Thilo,Ornstein Deborah,Ozelo Margarete,Panetta John Carl,Neufeld Ellis J.,P'Ng Stephanie,Peerlinck Kathelijne,Pollio Berardino,Pouplard Claire,Gruel Yves,Prezotti Alessandra,Price Vicky,Primacakti Fitri,Puyade Mathieu,Radossi Paolo,Raffini Leslie,Ragni Margaret,Rangarajan Savita,Reding Mark T.,Reid Robin,Restrepo Jose,Ramirez Jose,Recht Michael,Rodriguez Lopez Manuel,Ruiz‐Sàez Arlette,Saleh Mahasen,Shapiro Amy,Sharathkumar Anjali,Selmeczi Anna,Simpson Mindy,Singleton Tami,Cruz Maria Sol,Soto Veronica,Steele MacGregor,Streif Werner,Sun Hao Wei,Ritchie Bruce,Sun Jing,Feng Xiaqin,Suzuki Takashi,Nagao Asuza,Takemoto Cliff,Tapp Heather,Teitel Jerry,Tinmouth Alan,Thornburg Courtney,Tosseto Alberto,Turnstall Oliver,Vezina Catherine,Warren Beth,Wheeler Allison,Wilches Gutierrez Juan D.,Wu John K.M.,Wynn Tung,Yang Renchi,Young Guy,Zanon Ezio,Zupan Irena,

Affiliation:

1. School of Pharmacy University of Waterloo Waterloo Ontario Canada

2. Department of Health Research Methods, Evidence, and Impact McMaster University Hamilton Ontario Canada

3. McMaster‐Bayer Research Chair in Clinical Epidemiology of Congenital Bleeding Disorders Department of Medicine McMaster University Hamilton Ontario Canada

Publisher

Wiley

Subject

Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/rth2.12204

Reference62 articles.

1. Clotting factor concentrates given to prevent bleeding, bleeding‐related complications in people with hemophilia A or B;Iorio A;Cochrane Database Syst Rev,2011

2. A longitudinal study of orthopaedic outcomes for severe factor-VIII-deficient haemophiliacs

3. Prophylaxis in bleeding disorders

4. Treatment of haemophilia A and B and von Willebrand’s disease: summary and conclusions of a systematic review as part of a Swedish health-technology assessment

5. When and how to start prophylaxis in boys with severe hemophilia without inhibitors: communication from the SSC of the ISTH

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effects of PK‐guided prophylaxis on clinical outcomes and FVIII consumption for patients with moderate to severe Haemophilia A;Haemophilia;2023-08-08

2. Anticoagulation and antiplatelet therapy in hereditary hemorrhagic telangiectasia: A scoping review;Thrombosis Research;2023-06

3. Limited sampling strategies for individualized BAX 855 prophylaxis in severe hemophilia A: in silico evaluation;Blood Coagulation & Fibrinolysis;2023-04

4. The Limitations and Unmet Needs of the Five Cornerstones to Guarantee Lifelong Optimization of Prophylaxis in Hemophilia Patients;TH Open;2022-10

5. Limited sampling strategies for individualized BAX 855 prophylaxis in severe hemophilia A: in silico evaluation;2022-08-29